Dr. Vincenzo Galati, DO

Dr. Galati practices at Cape Girardeau Urology Associates, Inc. in Cape Girardeau, Missouri.

Dr. Galati's NPI, 1376693754, was assigned on January 10, 2007. Dr. Galati graduated from Kirksville College of Osteopathic Medicine in 2004. Dr. Galati holds Missouri license 2009005528.

Dr. Galati's primary practice is Cape Girardeau Urology Associates, Inc., at 3 Doctors Park Dr, Cape Girardeau, MO 63703 in Cape Girardeau County. The practice phone is (573) 334-7748.

Dr. Galati's primary practice is Cape Girardeau Urology Associates, Inc. in Cape Girardeau, Missouri. Dr. Galati is also affiliated with Saint Francis Medical Center. The medical group on file is Cape Girardeau Urology Associates. Dmand AI also links Dr. Galati to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Galati practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Galati's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Galati is board certified in urology by the American Board of Urology. Dr. Galati is licensed in Missouri.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and pelvic prolapse among the conditions Dr. Galati treats.

CMS data shows 9,892 Medicare services from Dr. Galati across 41 procedure codes in 2024, for 712 Medicare patients. Medicare paid $208,275 for them.

CMS counts 712 Medicare patients who saw Dr. Galati in 2024. The largest group is 65 to 74, with 336 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.16, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Galati's median patient age at 72, with 26% women.

In 2024, Dr. Galati wrote 1,299 Medicare Part D claims for 415 patients. 86% of them were for generic drugs. CMS names the drug for 1,180 of them, across 19 drugs with 11 or more claims each, at $98,473 in total drug cost. In 2023, CMS named 1,712 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Galati for performance year 2024, reported as part of a group. Dr. Galati accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 39 procedures of prostate resection by Dr. Galati, more than 95% of the clinicians it reports for that procedure.

Dmand AI links 16 papers to Dr. Galati, published from 2007 to 2015. 2014 was the busiest year, with 2. The most frequent topics are Anti-Bacterial Agents, HIV Infections and Ultrasonography. Dr. Galati has published most often in J Clin Virol. Dr. Galati's most frequent co-authors are Dominic Frimberger, MD, Jeffrey Campbell, MD and Bradley P. Kropp, MD.

CMS Open Payments shows 561 general payments to Dr. Galati from 57 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 87% of the total. Astellas Pharma US Inc paid the most, $2,016.

Dmand AI lists 13 awards for Dr. Galati, most recently Prostatectomy Excellence Award, Southeast Hospital in 2012. Dr. Galati serves on Medical Executive Committee Southeast Hospital.

Dr. Galati graduated from Kirksville College of Osteopathic Medicine in 2004. Dr. Galati is a member of ACS, AMA, AOA and AUA.

Dr. Galati is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.